Evotec SE (EVO) income statement
EVONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as EVOTF
$1.32−0.13 (-8.97%)
Close on Nov 20, 2026Market cap $469.34MP/E –Yield –
Evotec SE financial ratios
See a number that looks wrong?
Close on Nov 20, 2026Market cap $469.34MP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||
| Gross margin | 14.5% | 14.4% | 22.4% | 23.2% | 24.5% | 25.1% | 29.8% | – |
| Operating margin | -7.1% | -17.9% | -6.1% | 2.8% | 6.6% | 9.7% | 14.0% | – |
| EBITDA margin | 5.5% | -5.1% | 5.8% | 13.8% | 18.0% | – | – | – |
| Pre-tax margin | -11.0% | -24.3% | -10.3% | -20.5% | 38.3% | 5.2% | 12.7% | – |
| Net profit margin | – | – | – | -23.4% | 34.9% | 1.3% | 8.5% | – |
| Free cash flow margin | -10.4% | -12.5% | -22.6% | 3.3% | 1.2% | -10.9% | 2.4% | – |
| Effective tax rate | – | – | – | – | 9.1% | 75.7% | 34.2% | – |
| Returns on capital | ||||||||
| Return on equity | – | – | – | -13.7% | 20.5% | 1.0% | 8.4% | – |
| Return on assets | – | – | – | -7.8% | 11.7% | 0.43% | – | – |
| Return on tangible assets | – | – | – | -9.0% | 13.8% | 0.56% | – | – |
| Return on invested capital | -7.7% | -15.9% | -4.1% | 1.5% | 4.4% | 3.0% | – | – |
| Return on capital employed | -3.9% | -8.5% | -2.6% | 1.1% | 2.6% | 3.9% | – | – |
| Return on total capital | -6.0% | -12.8% | -3.4% | 1.3% | 2.9% | 4.5% | – | – |
| NOPAT | -44.41M | -112.59M | -37.53M | 16.47M | 37.28M | 19.42M | 41.28M | – |
| Cash flow quality | ||||||||
| OCF / Sales | -1.2% | 2.3% | 4.7% | 27.4% | 20.5% | 8.9% | 9.5% | – |
| OCF / Net income | – | – | – | -1.17 | 0.59 | 7.12 | 1.11 | – |
| FCF / OCF | 890.3% | -544.7% | -485.4% | 11.9% | 6.0% | -121.5% | 25.8% | – |
| FCF / Net income | – | – | – | -0.14 | 0.04 | -8.66 | 0.29 | – |
| FCF / EBITDA | -188.9% | 242.6% | -389.0% | 23.5% | 6.9% | – | – | – |
| Unlevered free cash flow | -81.72M | -99.25M | -176.88M | 34.85M | 14.97M | -47.66M | 16.78M | – |
| Levered free cash flow | -81.72M | -99.25M | -176.88M | 24.46M | 7.66M | -54.35M | 10.89M | – |
| Efficiency | ||||||||
| Asset turnover | 0.43 | 0.38 | 0.35 | 0.33 | 0.33 | 0.34 | – | – |
| Fixed asset turnover | – | – | – | 1.32 | 1.50 | 1.74 | 1.87 | – |
| Receivables turnover | 6.25 | 7.42 | 5.78 | 4.95 | 5.86 | 6.34 | – | – |
| Days sales outstanding | 58.4 | 49.2 | 63.1 | 73.8 | 62.3 | 57.6 | – | – |
| Payables turnover | 8.96 | 6.20 | 5.24 | 5.94 | – | – | – | – |
| Days payables outstanding | 40.8 | 58.9 | 69.7 | 61.5 | – | – | – | – |
| Inventory turnover | 22.31 | 22.00 | 19.97 | 20.76 | 23.69 | 27.62 | – | – |
| Days inventory outstanding | 16.4 | 16.6 | 18.3 | 17.6 | 15.4 | 13.2 | – | – |
| Operating cycle | 74.8 | 65.8 | 81.4 | 91.4 | 77.7 | 70.8 | – | – |
| Cash conversion cycle | 34.0 | 6.9 | 11.7 | 29.9 | – | – | – | – |
| CapEx to revenue | 9.2% | 14.7% | 27.3% | 24.1% | 19.2% | 19.8% | 7.0% | – |
| CapEx to OCF | -790.3% | 644.7% | 585.4% | 88.1% | 94.0% | 221.5% | 74.2% | – |
| CapEx to depreciation | 0.73 | 1.16 | 2.29 | 2.18 | 1.69 | – | – | – |
| Liquidity | ||||||||
| Current ratio | 2.07 | 1.98 | 1.94 | 3.18 | 3.39 | 3.16 | – | – |
| Quick ratio | 1.99 | 1.89 | 1.88 | 3.09 | 3.31 | 3.10 | – | – |
| Cash ratio | 1.14 | 0.89 | 1.10 | 1.23 | 2.15 | 2.03 | – | – |
| Working capital | 394.87M | 337.38M | 438.59M | 735.97M | 776.42M | 450.39M | – | – |
| Net current asset value | -137.30M | -278.01M | -229.40M | 3.61M | 243.46M | -79.04M | – | – |
| Leverage | ||||||||
| Total debt | 81.50M | 27.11M | 129.97M | 329.85M | 362.48M | 346.41M | – | – |
| Net debt | -337.02M | -279.27M | -380.94M | -85.30M | -336.85M | -76.17M | – | – |
| Debt / Equity | 0.10 | 0.03 | 0.12 | 0.28 | 0.26 | 0.48 | – | – |
| Debt ratio | 4.8% | 1.4% | 5.8% | 14.6% | 16.2% | 23.7% | – | – |
| Assets to equity | 2.11 | 2.01 | 2.01 | 1.90 | 1.62 | 2.02 | – | – |
| Long-term debt to assets | – | – | – | 14.5% | 14.6% | 22.6% | – | – |
| Long-term debt to equity | – | – | – | 0.28 | 0.24 | 0.46 | – | – |
| Total debt / Capitalization | 9.1% | 2.8% | 10.4% | 21.7% | 20.8% | 32.3% | – | – |
| Long-term debt / Capitalization | – | – | – | 21.7% | 19.2% | 31.4% | – | – |
| Net debt / EBITDA | -7.79 | 6.83 | -8.38 | -0.82 | -3.02 | – | – | – |
| Total debt / EBITDA | 1.88 | -0.66 | 2.86 | 3.17 | 3.25 | – | – | – |
| Cash flow to debt | -11.3% | 67.2% | 28.0% | 62.4% | 34.9% | 12.9% | – | – |
| Goodwill / Assets | 15.9% | 14.8% | 12.2% | 12.2% | 11.5% | 16.9% | – | – |
| Intangibles to total assets | 17.7% | 16.2% | 12.9% | 13.2% | 12.9% | 23.6% | – | – |
| Interest coverage | ||||||||
| EBIT / Interest expense | – | – | – | 1.59 | 4.43 | 5.74 | 8.41 | – |
| EBITDA / Interest expense | – | – | – | 7.91 | 12.04 | – | – | – |
| (EBITDA − CapEx) / Interest expense | – | – | – | -5.88 | -0.82 | – | – | – |
| Per share | ||||||||
| Revenue per share | 4.43 | 4.49 | 4.41 | 4.25 | 3.50 | 3.06 | 2.98 | – |
| EPS (basic) | -0.58 | -1.11 | -0.47 | -0.99 | 1.30 | 0.04 | 0.25 | – |
| EPS (diluted) | -0.58 | -1.11 | -0.47 | -0.99 | 1.30 | 0.04 | 0.25 | – |
| Book value per share | 4.58 | 5.36 | 6.32 | 6.71 | 7.80 | 4.42 | 3.20 | – |
| Tangible book value per share | 2.87 | 3.62 | 4.68 | 5.02 | 6.17 | 2.31 | 0.71 | – |
| Cash per share | 2.35 | 1.73 | 2.88 | 2.35 | 3.96 | 2.58 | 1.85 | – |
| Operating cash flow per share | -0.05 | 0.10 | 0.21 | 1.16 | 0.72 | 0.27 | 0.28 | – |
| Free cash flow per share | -0.46 | -0.56 | -1.00 | 0.14 | 0.04 | -0.33 | 0.07 | – |
| CapEx per share | 0.41 | 0.66 | 1.20 | 1.02 | 0.67 | 0.60 | 0.21 | – |
| Valuation at period end | ||||||||
| Market cap | 1.09B | 1.47B | 4.15B | 2.86B | 7.79B | 5.49B | – | – |
| Enterprise value | 765.97M | 1.08B | 4.06B | 2.50B | 7.70B | 5.16B | – | – |
| P/E | – | – | – | – | 36.1x | 875x | – | – |
| P/S | 1.4x | 1.8x | 5.3x | 3.8x | 12.6x | 11.0x | – | – |
| P/B | 1.3x | 1.5x | 3.7x | 2.4x | 5.7x | 7.6x | – | – |
| P/TBV | 2.1x | 2.3x | 5.0x | 3.2x | 7.1x | 14.5x | – | – |
| P/Gross profit | 9.6x | 12.8x | 23.7x | 16.4x | 51.4x | 43.7x | – | – |
| P/OCF | -119x | 80.9x | 114x | 13.9x | 61.5x | 123x | – | – |
| P/FCF | – | – | – | 117x | 1,017x | – | – | – |
| EV/Sales | 1.0x | 1.4x | 5.2x | 3.3x | 12.5x | 10.3x | – | – |
| EV/Gross profit | 6.7x | 9.4x | 23.2x | 14.3x | 50.8x | 41.0x | – | – |
| EV/EBITDA | 17.7x | – | 89.2x | 24.0x | 69.1x | – | – | – |
| EV/EBIT | – | – | – | 120x | 188x | 106x | – | – |
| EV/OCF | -83.4x | 59.3x | 111x | 12.1x | 60.8x | 115x | – | – |
| EV/FCF | – | – | – | 102x | 1,006x | – | – | – |
| Earnings yield | – | – | – | -6.1% | 2.8% | 0.11% | – | – |
| FCF yield | -7.5% | -6.7% | -4.3% | 0.86% | 0.10% | -0.99% | – | – |
| Shareholder yield | ||||||||
| Buyback yield | 0.14% | – | – | – | – | – | – | – |
| Debt paydown yield | 0.53% | 8.7% | -2.6% | 1.2% | -0.19% | -0.27% | – | – |
| Shareholder yield | 0.14% | – | – | – | – | – | – | – |
| Cost structure | ||||||||
| R&D to revenue | 4.8% | 6.4% | 8.8% | 10.2% | 11.7% | 12.8% | 13.1% | – |
| SG&A to revenue | 22.3% | 23.6% | 21.7% | 20.8% | 17.1% | 15.4% | 14.9% | – |
| Stock-based comp to revenue | 0.48% | 0.63% | 1.2% | 1.3% | 1.3% | 1.1% | 0.82% | – |
| Per employee | ||||||||
| Total employees | 4,553 | 4,827 | 5,160 | 4,952 | 4,198 | 147 | 147 | 147 |
| Revenue per employee | 173.15K | 165.11K | 151.44K | 151.75K | 147.22K | 3.41M | 3.04M | – |
| Gross profit per employee | 25.09K | 23.80K | 33.92K | 35.15K | 36.10K | 855.39K | 904.02K | – |
| Operating profit per employee | -12.35K | -29.53K | -9.21K | 4.21K | 9.77K | 330.31K | 426.58K | – |
| Net income per employee | – | – | – | -35.47K | 51.34K | 42.71K | 259.56K | – |
| Free cash flow per employee | -17.95K | -20.56K | -34.28K | 4.94K | 1.82K | -369.73K | 74.11K | – |
| Growth | ||||||||
| Revenue 1Y growth | -1.1% | 2.0% | 4.0% | 21.6% | 23.4% | 12.2% | – | – |
| Revenue 3Y CAGR | 1.6% | 8.8% | 16.0% | 19.0% | – | – | – | – |
| Revenue 5Y CAGR | 9.5% | 12.3% | – | – | – | – | – | – |
| Gross profit 1Y growth | -0.57% | -34.4% | 0.57% | 14.9% | 20.5% | -5.4% | – | – |
| Gross profit 3Y CAGR | -13.1% | -8.8% | 11.7% | 9.4% | – | – | – | – |
| Gross profit 5Y CAGR | -1.9% | -2.9% | – | – | – | – | – | – |
| EBIT 1Y growth | 60.6% | -200.0% | -327.9% | -49.1% | -15.6% | -22.6% | – | – |
| EBIT 3Y CAGR | – | – | – | -30.7% | – | – | – | – |
| EBITDA 1Y growth | 205.8% | -190.0% | -56.3% | -6.6% | – | – | – | – |
| EBITDA 3Y CAGR | -25.4% | – | – | – | – | – | – | – |
| Net income 1Y growth | – | – | – | -181.5% | 3,332.8% | -83.5% | – | – |
| Diluted EPS 1Y growth | 47.7% | -136.2% | 52.5% | -176.2% | 3,150.0% | -84.0% | – | – |
| Operating cash flow 1Y growth | -150.4% | -50.0% | -82.3% | 62.6% | 183.1% | 5.9% | – | – |
| Operating cash flow 3Y CAGR | – | -47.6% | -6.6% | 69.6% | – | – | – | – |
| Operating cash flow 5Y CAGR | – | -15.5% | – | – | – | – | – | – |
| Free cash flow 1Y growth | 17.7% | 43.9% | -823.2% | 219.4% | 114.1% | -598.9% | – | – |
| Free cash flow 3Y CAGR | – | – | – | 30.9% | – | – | – | – |
| CapEx 1Y growth | -38.2% | -44.9% | 17.6% | 52.5% | 20.1% | 216.3% | – | – |
| CapEx 3Y CAGR | -26.3% | -0.42% | 29.1% | 79.6% | – | – | – | – |
| CapEx 5Y CAGR | -6.0% | 30.3% | – | – | – | – | – | – |
| Total assets 1Y growth | -10.4% | -15.1% | -0.21% | 0.99% | 52.8% | – | – | – |
| Total assets 3Y CAGR | -8.8% | -5.1% | 15.5% | – | – | – | – | – |
| Total assets 5Y CAGR | 3.2% | – | – | – | – | – | – | – |
| Total equity 1Y growth | -14.6% | -14.9% | -5.7% | -13.8% | 90.2% | – | – | – |
| Total equity 3Y CAGR | -11.8% | -11.6% | 15.6% | – | – | – | – | – |
| Total equity 5Y CAGR | 2.4% | – | – | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.